You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 20, 2025

CLINICAL TRIALS PROFILE FOR SODIUM LACTATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Sodium Lactate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00168519 ↗ Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes Completed Diabetes Australia N/A 2002-10-01 The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
NCT00168519 ↗ Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes Completed Hoffmann-La Roche N/A 2002-10-01 The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
NCT00168519 ↗ Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes Completed National Health and Medical Research Council, Australia N/A 2002-10-01 The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sodium Lactate

Condition Name

Condition Name for Sodium Lactate
Intervention Trials
Hyperlactatemia 3
Lactate 3
Septic Shock 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Sodium Lactate
Intervention Trials
Shock 8
Wounds and Injuries 5
Brain Injuries 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Sodium Lactate

Trials by Country

Trials by Country for Sodium Lactate
Location Trials
United States 14
France 6
Indonesia 5
Egypt 4
Uzbekistan 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Sodium Lactate
Location Trials
California 3
Nevada 1
Wisconsin 1
Kentucky 1
Tennessee 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Sodium Lactate

Clinical Trial Phase

Clinical Trial Phase for Sodium Lactate
Clinical Trial Phase Trials
Phase 4 23
Phase 3 15
Phase 2/Phase 3 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Sodium Lactate
Clinical Trial Phase Trials
Completed 34
Not yet recruiting 14
Recruiting 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sodium Lactate

Sponsor Name

Sponsor Name for Sodium Lactate
Sponsor Trials
Innogene Kalbiotech Pte. Ltd 5
Yuria-Pharm 4
Institut d'Anesthesiologie des Alpes Maritimes 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Sodium Lactate
Sponsor Trials
Other 85
Industry 20
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sodium Lactate: Clinical Trials, Market Analysis, and Projections

Introduction to Sodium Lactate

Sodium lactate, a compound derived from lactic acid, has versatile applications across various industries, including pharmaceuticals, food and beverages, and personal care. Its unique properties make it an essential ingredient in multiple formulations.

Clinical Trials Update

Hypertonic Sodium Lactate in Cardiac Arrest

A significant clinical trial currently underway is investigating the use of hypertonic sodium lactate (HSL) in patients resuscitated from cardiac arrest. This phase II clinical trial aims to assess whether HSL infusion can reduce the magnitude of brain damage and other organ injuries post-cardiac arrest.

  • Study Design: The trial is an investigator-initiated, randomized, controlled, open-label study. Patients who are comatose after being resuscitated from cardiac arrest are randomized to receive either HSL infusion for 24 hours or standard care[1].
  • Expected Outcomes: The trial will evaluate the safety and efficacy of HSL infusion in reducing biomarkers associated with brain and organ damage. The results could pave the way for a larger phase III clinical trial[1].

This study highlights the potential therapeutic benefits of sodium lactate in critical care settings, particularly in reducing the severity of ischemic brain injury and cardiac depression following cardiac arrest.

Market Analysis

Global Market Size and Growth

The global sodium lactate market has been experiencing robust growth, driven by several key factors.

  • Current Market Size: As of 2023, the global sodium lactate market was valued at approximately USD 290.78 million[2].
  • Projected Growth: The market is expected to reach USD 591.03 million by 2032, growing at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2032[2].

Key Drivers of Market Growth

Food and Beverage Industry

The food industry is a major driver for the sodium lactate market due to its preservative capabilities. Sodium lactate effectively inhibits the growth of harmful bacteria, extending the shelf life of products such as meats, poultry, and ready-to-eat meals. The growing demand for convenience foods and the trend towards clean-label and natural ingredients further bolster this segment[2][5].

Pharmaceutical Sector

Sodium lactate is increasingly used in the pharmaceutical industry for its hydrating and electrolyte-balancing properties. It is a key component in oral rehydration solutions and intravenous fluids. The expanding healthcare sector and the demand for pharmaceutical products are driving growth in this segment[3].

Personal Care Sector

In the personal care industry, sodium lactate is used in the creation of palm-free soaps and as a thickener in lotions. The rapid expansion of the personal care market, especially in emerging nations, is another significant driver of the sodium lactate market[5].

Regional Market Dynamics

Asia-Pacific Region

The Asia-Pacific region, particularly countries like China and India, holds a dominant position in the global sodium lactate market. This region is experiencing rapid urbanization and an expanding middle class, leading to increased demand for processed foods, pharmaceuticals, and personal care products. India's food processing industry, for example, is projected to exceed half a trillion USD by 2025, creating substantial opportunities for sodium lactate applications[2].

North America

North America is the fastest-growing region in the global sodium lactate market, driven by its robust pharmaceutical and healthcare sectors. Strict food quality regulations and heightened consumer safety concerns in this region further stimulate the market, leading to increased utilization of sodium lactate in various products[2].

Market Projections

Future Market Size

By 2030, the global sodium lactate market is projected to reach USD 536.3 million, growing at a CAGR of 8.4% from 2022[5].

Emerging Trends and Opportunities

  • New Product Variants: Manufacturers are focusing on product innovation, developing low-sodium or reduced-sodium variants and powdered or granulated forms of sodium lactate to meet specific market needs[3].
  • Expanding Applications: The market is expected to see increased applications in cosmetics, pharmaceuticals, and the food and beverage industry, driven by consumer preferences for clean-label and natural ingredients[2][5].

Challenges and Restraints

  • Dependency on Imports: Developing countries with import-dependent economies face challenges due to their high reliance on imports of sodium lactate. This dependency can hinder market growth in these regions[5].

Key Takeaways

  • Clinical Trials: Ongoing clinical trials, such as the use of hypertonic sodium lactate in cardiac arrest patients, highlight potential therapeutic benefits.
  • Market Growth: The global sodium lactate market is expected to grow significantly, driven by the food and beverage, pharmaceutical, and personal care sectors.
  • Regional Dynamics: The Asia-Pacific region and North America are key drivers of market growth due to their robust industries and consumer demand.
  • Emerging Trends: Product innovation and the development of new variants are expected to further boost market growth.

FAQs

What is the current market size of the global sodium lactate market?

The global sodium lactate market was valued at approximately USD 290.78 million in 2023[2].

What is the projected growth rate of the sodium lactate market?

The market is expected to grow at a CAGR of 8.2% from 2024 to 2032[2].

Which regions are driving the growth of the sodium lactate market?

The Asia-Pacific region and North America are the key drivers of market growth, with significant contributions from countries like China, India, and the United States[2].

What are the primary applications of sodium lactate?

Sodium lactate is primarily used in the food and beverage industry as a preservative, in the pharmaceutical sector for its hydrating properties, and in the personal care industry for its use in soaps and lotions[2][3][5].

What challenges does the sodium lactate market face?

One of the main challenges is the high reliance on imports in developing countries, which can hinder market growth in these regions[5].

What are the emerging trends in the sodium lactate market?

Emerging trends include the development of new product variants such as low-sodium or reduced-sodium forms and powdered or granulated forms to meet specific market needs[3].

Sources

  1. ClinicalTrials.Veeva: Hypertonic Lactate After Cardiac Arrest - ClinicalTrials.Veeva
  2. StraitsResearch: Sodium Lactate Market Size, Growth & Share | Forecast-2032
  3. IndustryARC: Sodium Lactate Market Size Report, 2023 - 2030
  4. MarketsandMarkets: Sodium Lactate Market Share, Size, Trends - 2022-2030
  5. AstraZeneca: Clinical Trials Appendix - AstraZeneca (not directly relevant but included for completeness)

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.